Rockefeller Capital Management L.P. - INHIBIKASE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 15 filers reported holding INHIBIKASE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,000
-50.0%
1,5000.0%0.00%–
Q2 2021$4,000–1,500–0.00%–
 Download
Other shareholders

There were no reported owners of INHIBIKASE THERAPEUTICS INC in Q2 2021.

NameSharesValueWeighting ↓
View complete list of INHIBIKASE THERAPEUTICS INC shareholders